University of East Anglia Featured PhD Programmes
King’s College London Featured PhD Programmes
University of Nottingham Featured PhD Programmes
"colorectal" AND "cancer"…×
10 miles

colorectal cancer PhD Projects, Programs & Scholarships

We have 24 colorectal cancer PhD Projects, Programs & Scholarships

  • "colorectal" AND "cancer" ×
  • clear all
Order by 
Showing 1 to 15 of 24
  Detecting hydrolytic enzymes driving colorectal cancer development
  Dr R Barry, Prof G Frost
Application Deadline: 31 July 2020

Funding Type

PhD Type

Colorectal cancer is linked with inflammation of the colon caused by poor diet, obesity and chronic inflammatory conditions like inflammatory bowel disease (IBD).
  Beetroot betanin as a natural antioxidant and anticancer agent: Effect of betanin on proliferation of epithelial and colorectal cancer lines
  Dr I Nyambayo, Dr I Morozov
Application Deadline: 15 June 2020

Funding Type

PhD Type

Coventry University (CU) is inviting applications from suitably-qualified graduates for a (fully-funded) PhD studentship. This PhD studentship is a joint project between Coventry University and Agrial Fresh Produce Limited, UK.
  Tumour microenvironment and colorectal cancer development: understanding the mechanisms of the tumour growth
  Prof D Kerr, Dr S Cai
Application Deadline: 24 July 2020

Funding Type

PhD Type

Our group has conducted a series of international adjuvant trials of chemotherapy for colorectal cancer (Kerr RS. et al, (2016), Lancet Oncol, 17, 1543 – 1557).
  Bioengineering of patient-derived explants (PDEs) and 3D organoid culture systems for tissue regeneration, cancer and drug discovery
  Dr A Shams Nateri
Applications accepted all year round

Funding Type

PhD Type

The intestine provides an attractive route to model biologically important intestinal processes and a unique opportunity for the direct identification and analysis of factors that contribute to development and maintenance of both normal as well as the development of neoplasia.
  Understanding how rural-dwellers respond to potential cancer symptoms: A mixed methods PhD project using a community-based cohort assessing prevalence and response to potential cancer symptoms
  Prof P Murchie, Dr J Allan, Dr R Vieira
Application Deadline: 29 May 2020

Funding Type

PhD Type

1. Background to the project. Scottish people living further from key healthcare facilities have less chance of prompt cancer diagnosis and poorer cancer survival than those living closer-by[1].
  Application of protein-drug conjugates for the treatment of cancer (part of the ETN Targeted Anti-Cancer Therapies “TACT”)
  Research Group: Centre for Cancer Research and Cell Biology
  Prof C Scott, Dr K McCloskey
Application Deadline: 1 June 2020

Funding Type

PhD Type

Macromolecular drug substances such as antibodies, ADCs and nanomedicine are often compromised in their therapeutic effectiveness due to inability to penetrate sufficiently into the diseased tissue and be taken up by the diseased cells.
  Chemotherapy dose-capping due to obesity and its impact on survival
  Prof A Renehan, Dr Jorge Barriuso
Applications accepted all year round

Funding Type

PhD Type

Obesity is associated with risk for several cancer types, including colorectal and breast cancers (1). Obesity also predicts for a poor outcome after cancer treatment.
  Investigating differentiation processes in normal and tumoral cells which affect phenotypic heterogeneity and stemness
  Dr P Ordonez Moran, Dr A Shams Nateri
Applications accepted all year round

Funding Type

PhD Type

Our research is focused on understanding tissue renewal in health and disease using the intestine as a model system to study adult stem cell biology for a therapeutic benefit.
  Inhibition of PRMT5 as a cancer therapy
  Dr K. Sheppard
Applications accepted all year round

Funding Type

PhD Type

Targeted therapy has had profound impact on outcomes for cancer patients.
  How can epigenetic changes be used to predict and prevent cancer?
  Dr A Chatterjee, Dr E Rodger
Applications accepted all year round

Funding Type

PhD Type

Our lab, led by international leader in epigenetics Dr Aniruddha Chatterjee, combines cutting edge next-generation sequencing, computational analysis, and experimental work to decipher the role of epigenetic modifications and cellular phenotype in cancer.
  Epigenetic therapy using ultrasound-mediated microbubble drug delivery for cancer treatment
  Dr E Valleley, Dr L Coletta
Applications accepted all year round

Funding Type

PhD Type

The project is an interdisciplinary, pre-clinical study that aims to investigate the response of human tumour cells to treatment with epigenetic inhibitors (such as DNA methyltransferase inhibitors), as a potential combination therapy for colorectal cancer (CRC).
  Watching cancer metastasise live and investigating the underlying mechanisms
  Dr K Campbell, Dr M J P Simons
Applications accepted all year round

Funding Type

PhD Type

Cancer metastasis accounts for around 90% of cancer deaths. While the survival rate has been improved over the years through early diagnosis, limited progress has been made in the targeting of metastasis.
  Endosomal Sorting Complex Required for Transport (ESCRT): Investigation of the role in acquired drug resistance in colon cancer
  Research Group: Institute of Cancer Therapeutics
  Dr S Shnyder, Dr S Kantamneni
Applications accepted all year round

Funding Type

PhD Type

Despite treatment advances, one of the most common cancers, colorectal cancer (CRC), still has a 45% mortality rate, and one of the major problems is the build-up of resistance to cancer drugs during treatment (‘acquired resistance’) such that over time the drugs stop working.
  Development of “FXR-targeted” Nutraceuticals for Treatment of Intestinal Diseases
  Prof S Keely, Dr S Das
Applications accepted all year round

Funding Type

PhD Type

The incidence of intestinal diseases, such as colorectal cancer (CRC) and inflammatory bowel disease (IBD), is significantly higher in Western societies than elsewhere in the world.
  The relationship between dietary iron and zinc, and the gut microbiota: Can dietary iron and zinc regime be exploited to improve health?
  Prof S C Andrews
Applications accepted all year round

Funding Type

PhD Type

"The gut microbiota (100 trillion cells) outnumber human cells by 10 to 1. Its composition of around 500 to 1000 species is specific for each individual and is dynamic, changing with age, health and diet.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2020
All rights reserved.